Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Aggression × Etoposide × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Lymphoma 204 Lymphoma, Large B-Cell, Diffuse 146 Small Cell Lung Carcinoma 136 Precursor Cell Lymphoblastic Leukemia-Lymphoma 130 Leukemia 128 Lymphoma, Non-Hodgkin 125 Leukemia, Myeloid, Acute 106 Hodgkin Disease 100 Burkitt Lymphoma 90 Lung Neoplasms 89 Lymphoma, Follicular 77 Lymphoma, Mantle-Cell 66 Lymphoma, Large-Cell, Immunoblastic 63 Leukemia, Lymphocytic, Chronic, B-Cell 54 Carcinoma, Non-Small-Cell Lung 52 Neuroblastoma 49 Recurrence 46 Multiple Myeloma 45 Lymphoma, B-Cell, Marginal Zone 40 Congenital Abnormalities 37 Sarcoma 36 Myelodysplastic Syndromes 34 Central Nervous System Neoplasms 34 Brain Neoplasms 32 Leukemia, Myelomonocytic, Acute 29 Leukemia, Monocytic, Acute 29 Leukemia, Erythroblastic, Acute 29 Ovarian Neoplasms 28 Dendritic Cell Sarcoma, Interdigitating 28 Leukemia, Megakaryoblastic, Acute 27

Interventions

selinexor 1 pegfilgrastim 1 midostaurin 1 glofitamab 1 Topotecan 1 Rituximab 1 Prednisone 1 Paclitaxel 1 Methylprednisolone 1 Immunologic Techniques 1 Ifosfamide 1 Flow Cytometry 1 Etoposide 1 Dexamethasone 1 Clofarabine 1 Carboplatin 1 Alemtuzumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02471911 2022-04-12

KPT-330+RICE

Weill Medical College of Cornell University

Phase 1 Completed

Aggression, Lymphoma, Large B-Cell, Diffuse

Data powered by HemOnc (CC BY 4.0) Colophon ⚡